CIVATECH ONCOLOGY, INC.

Basic Information

2810 MERIDIAN PKWY STE 148
DURHAM, NC, 27713-2234

http://www.civatechoncology.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 801431862
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 13


  1. IGF::OT::IGF OTHER FUNCTIONS DEVELOPMENT OF A UNI-DIRECTIONAL BRACHYTHERAPY DEVICE FOR THE TREATMENT OF NON-SMALL-CELL LUNG CANCER

    Amount: $998,964.00

    According to the American Cancer Society 220,000 men and women in the U.S. develop lung and bronchial cancer every year and 147,000 die of the disease. Of lung cancer patients, 85% present with non-sm ...

    SBIR Phase II 2012 Department of Health and Human Services
  2. Not Available

    Amount: $199,266.00

    The use of LDR brachytherapy after sub-lobar lung resection is the focus of a phase III NCI sponsored trial. Early clinical results from independent studies suggest that brachytherapy enables a singif ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government